Method for Treating Spinal Cord Injury and Paralysis
- Technology Benefits
- Despite the inability of adult CNS to regenerate and the inhibitory environment in the CNS, this method enhances the survival of stem cells that have been grafted into the nervous system, improves functional recovery and alleviates neurological deficits.
- Detailed Technology Description
- UCSD researchers have discovered that neural stem cells that were grafted into the site of spinal cord injury will differentiate into neurons with long-extending axons that can synapse with host cells, and result in functional recovery in an animal model. In addition, UCSD investigators have found that adding a novel mixture of polymerizing compounds and growth factors with stem cell grafts dramatically improves neuron survival and functional recovery. This allows early stage neurons to repair lesions in the adult central nervous system (CNS) by surviving, extending their axons and integrating with adult neurons through synapse formation.
- Supplementary Information
- Inventor: LU, Paul | TUSZYNSKI, Mark H.
Priority Number: WO2013090205A2
IPC Current: A61K003512 | A61K003524 | A61K003818 | A61P002100 | A61P002500
Assignee Applicant: The Regents of the University of California
Title: METHODS FOR USE OF NEURAL STEM CELL COMPOSITIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM LESIONS | MÉTHODES D'UTILISATION DE COMPOSITIONS DE CELLULES SOUCHES NEURALES POUR TRAITER DES LÉSIONS DU SYSTÈME NERVEUX CENTRAL
Usefulness: METHODS FOR USE OF NEURAL STEM CELL COMPOSITIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM LESIONS | MÉTHODES D'UTILISATION DE COMPOSITIONS DE CELLULES SOUCHES NEURALES POUR TRAITER DES LÉSIONS DU SYSTÈME NERVEUX CENTRAL
Summary: The method is useful for: treating a lesion in the post-embryonic CNS of a subject, preferably human (all claimed); and inducing formation of functional synaptic junctions and corticospinal regeneration in the spinal cord. Tests details are described but no results given.
- Industry
- Disease Diagnostic/Treatment
- Sub Category
- Neuron Disease
- Application No.
- 9649358
- Others
-
State Of Development
The neuronal regeneration and functional recovery by the injected neural stem cells have been demonstrated in animal models. In addition, in vivo animal models of SCI show that in rat embryonic neural grafts, the novel mixture dramatically improves graft survival, enhances anatomical repair of the nervous system and improves functional outcomes.
Intellectual Property Info
Patent rights are available for licensing.
Related Materials
Motor axonal regeneration after partial and complete spinal cord transection. Lu P, Blesch A, Graham L, Wang Y, Samara R, Banos K, Haringer V, Havton L, Weishaupt N, Bennett D, Fouad K, Tuszynski MH. J Neurosci. 2012 Jun 13;32(24):8208-18.
Lu P, Wang Y, Graham L, McHale K, Gao M, Wu D, Brock J, Blesch A, Rosenzweig ES, Havton LA, Zheng B, Conner JM, Marsala M, Tuszynski MH. Cell. 2012 Sep 14;150(6):1264-73.
UCSD finds possible treatment for paralysis
Lu P, Woodruff G, Wang Y, Graham L, Hunt M, Wu D, Boehle E, Ahmad R, Poplawski G, Brock J, Goldstein LS, Tuszynski MH. • Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury. Neuron. 2014 Aug 20;83(4):789-96.Tech ID/UC Case
22677/2011-227-0
Related Cases
2011-227-0
- *Abstract
-
Unlike most other tissues in the human body, which have the ability to heal themselves after injury, damaged axons in the spinal cord cannot heal and recover their function by regenerating or synapsing with other neurons. Despite recent successes in models of partial spinal cord injury (SCI), there is great unmet need in solutions that lead to axonal regeneration and functional recovery after complete spinal cord transection.
- *IP Issue Date
- May 16, 2017
- *Principal Investigator
-
Name: Paul Lu
Department:
Name: Paul Lu
Department:
Name: Mark Tuszynski
Department:
Name: Mark Tuszynski
Department:
- Country/Region
- USA
